Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical-stage ...

This program supports undergraduate, graduate, and medical students conducting lupus-focused research under the guidance of experienced mentors.

Como reumatólogo practicante, he descubierto que la mayoría de las personas con lupus aprenden, con el tiempo, cómo sobrellevar la enfermedad. El apoyo familiar ayuda muchísimo. También es importante ...

As a practicing rheumatologist, I have found that most people with lupus learn, over time, how to cope with the disease. Family support helps a tremendous amount. A good doctor-patient relationship is ...

Most of us will be faced with the need for surgery at some point in our lives. Surgery may present some particular challenges in people who have lupus, so proper preparation is important. Although we ...

People who live with chronic diseases such as lupus often come to value health care providers who give particularly attentive and effective care. But what many don’t realize is that while you may be ...

Most physicians with experience in lupus agree that antimalarial treatments such as hydroxychloroquine (Plaquenil), chloroquine (Aralen) or quinicrine (Atabrine) should be used long-term, ...

Cheryl Russell of Highland Beach, FL, doesn’t indulge in what she calls “symptom chasing.” After more than three decades with lupus, she refuses to head to the doctor every time she has joint pain or ...

When you’re living with lupus, it can impact all aspects of your daily life, including your ability to work and finances. For many, lupus symptoms like fatigue and pain can make it very difficult — or ...

Lupus is an unpredictable and misunderstood autoimmune disease. It is difficult to diagnose, hard to live with, and a challenge to treat. Lupus has a range of symptoms, and strikes without warning.

New study finds that elevated S100A8/A9 levels in blood may be associated with cognitive impairment in adults with #lupus.

In a new study, researchers identified eight disease activity domains for further development into the new Treatment Response Measure for Systemic Lupus Erythematosus (TRM-SLE), a clinical trial ...